食药用真菌多糖及复合多糖生物活性研究

食药用真菌多糖有多种生物学功能,在抗肿瘤、免疫调节作用、抗衰老、降血脂等方面发挥着重要的生物活性.对正常细胞无毒副作用是食药用真菌多糖的突出优点.合适剂量食药用真菌多糖配伍使用时,各多糖间药理作用呈现协同性,可以提高在抗肿瘤、免疫调节等方面的药效.     

食（药）用真菌比较基因组分析揭示其生态特性

食（药）用真菌可以产生多种酶系家族来降解环境中的木质纤维素,从而获得营养或与植物共生或寄生。通过注释和比较不同营养模式的食（药）用真菌中降解木质纤维素的酶类,有利于我们更好地认识食（药）用真菌的生活模式,并进一步改善培养条件。本文系统地研究了46个食（药）用真菌和3个降解木质纤维素模式真菌的基因组,根据预测蛋白质组解析了糖苷水解酶（glycoside hydrolases,GHs）、糖基转移酶（glycosyltransferases,GTs）、多糖裂解酶（polysaccharide lyases,PLs）、碳水化合物酯酶（carbohydrate esterases,CEs）、碳水化合物结合模块（carbohydrate-binding modules,CBMs）以及附属活力酶（auxiliary activities,AAs）和细胞色素P450（cytochromes P450）的种类分布。比较基因组学结果显示,食（药）用真菌中降解木质纤维素相关酶系家族的数量和种类差别很大,同时酶系家族的多样性与食（药）用真菌的生态类型也有一定的相关性。一般情况下,腐生营养真菌比共生营养真菌中降解木质纤维素酶类更多,而腐生营养中的白腐真菌和草腐真菌的酶系比褐腐真菌多。     

食药用真菌多糖构效关系研究进展

真菌多糖具有抗病毒、抗凝血、抗肿瘤、免疫调节、降血脂、延缓衰老等多种生物活性,而多糖的功能与结构密切相关。多糖结构与功能关系的研究已经成为人们关注的一个热点。综述了食药用真菌多糖一级结构、高级结构及多糖的理化性质与其生物学活性之间的关系。     

食药用真菌多糖对肿瘤免疫逃逸调节作用机制研究进展

食药用真菌多糖是食药用真菌的主要天然生物活性成分,可以从多层次、多靶点调节机体的免疫功能,被认为是一种天然免疫调节剂。此前食药用真菌多糖抗肿瘤机制研究集中在提升机体的免疫力达到抑制肿瘤的目的,但近年的研究表明它可以调节肿瘤微环境,恢复机体对肿瘤以及肿瘤微环境的监视能力,提升机体对肿瘤微环境的特异性免疫应答能力,进而达到充分发挥其抑制和杀伤肿瘤的功能。我们课题组前期研究中也发现食药用菌多糖可以正向调节肿瘤小鼠外周血免疫细胞数量,促进免疫细胞浸润到肿瘤微环境中帮助机体识别及杀伤肿瘤细胞,改善肿瘤微环境免疫状态。本文在我们团队的研究工作的基础上,结合国内外文献总结食药用真菌多糖作为免疫调节剂在抑制肿瘤免疫逃逸中的生物活性,结合肿瘤微环境探讨其与肿瘤免疫的关系、作用机制和在肿瘤治疗中的作用,以期为食药用真菌多糖免疫治疗提供新思路。     

食药用真菌寡糖研究进展及展望

食药用真菌中多糖和寡糖独特的生物学活性引起了广泛的关注。寡糖一般通过多糖降解获得,与多糖相比,寡糖分子量低、结构相对简单、易于吸收。挖掘高活性寡糖链,阐明寡糖结构和活性的构效关系,有助于突破解析多糖复杂结构的技术瓶颈,揭示食药用真菌药理活性的作用机制。目前,人（乳）、动物和微生物（细菌）源的寡糖开发利用已有大量研究报道,而食药用真菌寡糖的研究还相对较少。文中系统总结了国内外食药用真菌寡糖的最新研究进展,详细评述了寡糖活性评价与结构鉴定的相关研究手段及成果。我国食药用真菌资源丰富,构建食药用真菌寡糖库,高通量筛选活性寡糖,阐明寡糖活性的作用机制对食药用真菌的产品开发,研发及临床应用食药用真菌相关保健品、药品,具有重要意义。     

分子标记在食（药）用真菌遗传多样性研究中的应用

食（药）用真菌在经济和生态方面都具有重要意义,其遗传多样性研究是资源可持续利用和生物保护学研究的基础,有利于食（药）用真菌种质资源的收集、保存、评价和利用,也有助于其分类学、系统学及进化等的研究。遗传多样性的研究方法很多,分子标记是目前最常用最有效的方法之一。综合分析了分子标记在食（药）用真菌遗传多样性研究中的应用,比较了各种标记的应用范围、优缺点,探讨了分子标记用于食（药）用真菌遗传多样性评价的前景及问题。     

食药用真菌多糖研究进展

综述了部分食药用真菌多糖的来源、化学研究及生物活性,着重探讨了其构效关系。结合到食药用真菌多糖研究开发现状和中药现代化,提出了值得关注的几个问题。     

食药用真菌多糖抗氧化作用研究进展

食药用真菌多糖由于其独特的生理活性,目前正成为国内外众多学科领域研究的热点之一。综述了食药用真菌多糖抗氧化作用研究现状、作用机理及其构效与量效关系,并对其发展前景进行了展望,旨在为其深入研究和开发利用提供参考。     

中国食（药）用真菌发酵工程研究进展

通过回顾食(药)用真菌生产工艺的研究历史,阐述了现代食(药)用真菌发酵工程包括液体发酵和固体发酵的研究状况,着重指出新型与多样性固体发酵工程的创建和发展可为人类提供取之不尽、用之不竭的传统生产工艺难以获得的珍贵目的产物。     

食线虫真菌侵染性胞外酶和生防应用

食线虫真菌作为重要的植物寄生线虫的生物防治资源,深入了解它们的侵染方式、毒力因子是了解食线虫真菌侵染的分子机理和开发高效、稳定的生物杀线虫制剂的关键。目前的研究表明,食线虫真菌能分泌具有降解线虫体壁或线虫卵壳的胞外酶,它们在食线虫真菌侵染线虫的过程中起着非常重要的作用。对这些侵染性胞外水解酶的深入研究将促进人们对食线虫真菌的侵染过程和侵染机制的了解以及高效生防制剂的开发。综述了近年来食线虫真菌侵染性胞外酶的研究概况,对食线虫真菌胞外丝氨酸蛋白酶进行同源性分析,对以后食线虫真菌侵染性胞外酶的研究和高效生防制剂开发进行了评述。     

药用真菌活性次级代谢产物研究

药用真菌作为我国传统中医药体系的重要组成部分,有着悠久的历史。它们能够产生丰富的活性次级代谢产物,具有神经保护、抗肿瘤、降血脂等诸多药效。然而,目前对大部分药用真菌次级代谢产物的化学和生物学研究较少。本课题组主要以抗肿瘤、抗炎、抗菌以及抗病毒等生物活性为指导,选择重要药用真菌进行化学研究,构建我国特色药用真菌代谢产物库。文章主要介绍近4年我们在这方面的研究进展。     

Estimation of the efficacy of screened natural hypolipidemic compounds in a model of rabbit hypercholesterolemia]

Thirteen strains producing hydrophobic compounds with high hypolipidemic activity were screened among 657 tested strains of fungi, actinomycetes and bacteria with the use of 2 models. The further aim of the study was to estimate the efficacy of the compounds with respect to their ability to inhibit cholesterol synthesis in vivo. For that purpose a model of hyperlipidemia in rabbits was used. The model provided screening of 9 new compounds that showed satisfactory hypolipidemic effect evident from a significant decrease of the lipid levels in the rabbit serum. The study of the serum lipid profile revealed that the inhibitory effect of compounds No. 16 and No. 281 was similar to that of lovastatin whereas the serum level of general cholesterol remained decreased for a longer period. Compound No. 25 was of interest because of its possible use in low doses and significant effect on the serum triglyceride fraction.     

Development of Monascus fermentation technology for high hypolipidemic effect

Monascus species has been used as the traditional food fungus in Eastern Asia for several centuries. Monascus-fermented products are gradually developed as the popular functional food for the prevention of cardiovascular disease, but we know that culture condition affects the hypolipidemic effect of Monascus-fermented product. In the past, the cholesterol-lowering agent--monacolin K--is regarded as the most important hypolipidemic agent. Two natural yellow pigments--monascin and ankaflavin--are also proven as novel hypolipidemic agents in recent years. However, the hypolipidemic effect of Monascus-fermented product should contribute from monacolin K, monascin, ankaflavin, and other unknown functional ingredients. In addition to hypolipidemic effect, the safety concern of Monascus-fermented product is involved in the levels of mycotoxin--citrinin. The hypolipidemic effect and the production of these functional metabolites or mycotoxin are influenced by many factors such as the choice of culture substrates, carbon and nitrogen source, pH value, extra nutrients, and so on. Therefore, this review focused on the effect of various culture conditions and nutrients on the functional metabolites production, hypolipidemic effect as well as citrinin concentration, and further organized the fermentation technologies used by previous studies for the promotion of hypolipidemic effect and safety.     

Screening of natural immunosuppressors by their ability to modify steroid synthesis in hepatocytes]

In the programme for screening sterol synthesis inhibitors with the use of actinomycetes and fungi 702 strains were tested. The effect of alcohol extracts of the mycelium of fungi and actinomycetes at a dilution of 1/10(3) on sterol synthesis by the Hep G2 hepatome cells was determined by incorporation of 3H acetate into sterols and proteins. Lovastatin (200 pg/ml) was used as the control: the sterol synthesis was decreased by 49 +/- 4% without inhibiting the protein synthesis. A number of the cultures produced compounds inhibiting under the experimental conditions the synthesis of sterols by 70 to 80% with simultaneous inhibition of the protein synthesis at least by 60 to 70%. Three compounds from that group produced by streptomycetes were subjected to a more detailed investigation. The compounds were demonstrated to be active antifungal antibiotics (MIC 0.1-1 mcg/ml). In a dose of 0.1-1 mcg/ml they showed high immunosuppressive activity in models of lymphocyte transformation in mice, whereas cyclosporin was active in a dose of 1 mcg/ml. Therefore, the model for screening hypolipidemic compounds could be considered useful for screening promising natural immunosuppressors.     

Biochemical effects of garlic protein on lipid metabolism in alcohol fed rats

Garlic protein is a very good hypolipidemic agent. In the present study the water soluble protein fraction of garlic was investigated for its effect on hyperlipidemia induced by alcohol (3.76 g/kg. body wt./day). The hypolipidemic action is mainly due to an increase in cholesterol degradation to bile acids and neutral sterols and mobilization of triacyl glycerols in treated rats. Garlic protein (500 mg./kg body wt./day) showed significant hypolipidemic action comparable with a standard dose of gugu-lipid (50 mg./kg. body wt./day).     

Acute effects of zopiclone on blood glucose level and serum lipids in hyperlipidemic rats. Interactions with PK 11195 and flumazenil

Intraperitoneal administration of 5 mg/kg zopiclone a cyclopyrolone acting on the central benzodiazepine receptors was found to produce significant reduction of total lipids, total cholesterol and triglyceride in rats randered hyperlipidemic by intraperitoneal injection of Triton W-1339. Blood glucose level was also reduced. Flumazenil (10 mg/kg) potentiated the hypoglicemic effect of zopiclone but had no additional effect on serum lipids. PK 11195 (25 mg/kg) antagonized the hypolipidemic effects of zopiclone. In conclusion: 1. The central benzodiazepine receptors are not involved in the hypolipidemic activity of zopiclone. 2. The peripheral type benzodiazepine receptors are partly responsible, for the hypolipidemic activity of this cyclopirrolone. 3. The changes of blood glucose level induced by these drugs does not seem to be related to benzodiazepine receptors.     

Hypolipidemic effect of beta, beta'-methyl-substituted hexadecanedioic acid (MEDICA 16) in normal and nephrotic rats

Treatment of normal or puromycin aminonucleoside-nephrotic rats, kept on a balanced Purina chow diet, with beta, beta'-tetramethyl-substituted hexadecanedioic acid (MEDICA 16) (Bar-Tana, J., G. Rose-Kahn, and M. Srebnik. 1985. J. Biol. Chem. 260: 8404-8410) resulted in an acute reversible inhibition of liver lipogenesis and cholesterogenesis with a concomitant hypolipidemic effect which was sustained as long as the drug was administered. The hypolipidemic effect in normal and nephrotic rats consisted of 70-80% and 40-60% reduction in plasma VLDL-triacylglycerols and cholesterol, respectively, with a respective increase in the HDL-cholesterol/(VLDL + LDL)-cholesterol ratio. The observed hypolipidemic effect was accompanied by a 10-fold decrease in VLDL-apoC-III content with a concomitant enrichment of the VLDL fraction by VLDL remnants having an increased apoB-100/apoB-48 ratio. The pharmacological reduction of VLDL by MEDICA 16 may offer a treatment mode of choice for selected hyperlipidemic states.     

Hypoglycemic and hypolipidemic effects and antioxidant activity of fruit extracts from Lycium barbarum

The hypoglycemic and hypolipidemic effects of Lycium barbarum fruit water decoction, crude polysaccharide extracts (crude LBP), and purified polysaccharide fractions (LBP-X) in alloxan-induced diabetic or hyperlipidemic rabbits were investigated through designed sequential trials and by measuring blood glucose and serum lipid parameters. Total antioxidant capacity was also assessed using trolox equivalent antioxidant capacity (TEAC) and oxygen radical absorbance capacity (ORAC) assay. It was found that the three Lycium barbarum fruit extracts/fractions could significantly reduce blood glucose levels and serum total cholesterol (TC) and triglyceride (TG) concentrations and at same time markedly increase high density lipoprotein cholesterol (HDL-c) levels after 10 days treatment in tested rabbits, indicating that there were substantial hypoglycemic and hypolipidemic effects. Hypoglycemic effect of LBP-X was more significant than those of water decoction and crude LBP, but its hypolipidemic effect seemed to be weaker. Total antioxidant capacity assay showed that all three Lycium barbarum extracts/fractions possessed antioxidant activity. However, water and methanolc fruit extracts and crude polysaccharide extracts exhibited stronger antioxidant activity than purified polysaccharide fractions because crude extracts were identified to be rich in antioxidants (e.g., carotenoids, riboflavin, ascorbic acid, thiamine, nicotinic acid). Lycium barbarum polysaccharides (glycocojugates), containing several monosaccharides and 17 amino acids, were major bioactive constituents of hypoglycemic effect. Both polysaccharides and vitamin antioxidants from Lycium barbarum fruits were possible active principles of hypolipidemic effect.     

Di-(2-ethylhexyl)phthalate: an industrial plasticizer induces hypolipidemia and enhances hepatic catalase and carnitine acetyltransferase activities in rat and mice.

Di-(2-ethylhexyl)phthalate (DOP), a plasticizer, when administered to rats and mice at a dietary concentration of 0.5 percent, 2 percent or 4 percent, caused a substantial reduction in serum cholesterol and triglyceride levels. The hypocholesterolemic and hypotriglyceridemic effects were more pronounced in rats fed DOP at 2 and 4 percent level than in mice. The hypolipidemic effect of this compound is associated with marked hepatomegaly in both species. The liver cells of both rats and mice fed this plasticizer for 1–4 weeks, revealed a considerable increase in peroxisome population. The elevations of hepatic catalase and carnitine acetyltransferase activities appeared to parallel the peroxisome proliferation induced by this compound. The hypolipidemic and peroxisome proliferative effects of this compound strongly suggest that all peroxisome proliferators possess hypolipidemic properties.     

Hypolipidemic Activity and Mechanism of Action of Sargassum fusiforme Polysaccharides

Sargassum fusiforme polysaccharide (SFP) is a kind of biologically active macromolecule with biological functions. In this study, oxidative stress and high-fat HepG2 cell models were established to investigate its lipid-lowering activity and mechanism of action. It was found that SFP and its two isolated fractions had antioxidant effects on the cells. It was also found the polysaccharides decreased the content of total cholesterol and total triglyceride in the high-fat cells. RT-qPCR assays revealed that the three polysaccharides down-regulated the mRNA expression level of ACC, PPARγ, and SREBP-2. It could be concluded that the hypolipidemic effect of SFPs is achieved via multiple pathways, including the regulation on the expression level of lipid metabolism-related key enzymes and factors, and binding with bile acids. The hypolipidemic effect of SFPs could be partially due to their antioxidant activity. SFPs developed in the present work have potential as ingredients of functional foods with hypolipidemic effect.